This pathway seeks to provide a way forward for future R&I policy in Europe and beyond. It is 1 out of 10 FOOD 2030 Pathways for Action, which target key R&I leverage points for transitioning towards sustainable, resilient, healthy and inclusive food systems that leave no one behind. The FOOD 20...
EFSA asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to update the scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim published in 2011. Since then, the NDA Panel has gained considerable experience in t...
The European Food Safety Authority (EFSA) asked the Panel on Dietetic Products Nutrition and Allergies (NDA) to update the General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims published in March 2011. Since then, the NDA Panel has completed the evaluatio...
Following a request from the European Commission, the EFSA Panel on Dietetic products, Nutrition and Allergies (NDA) was asked to provide scientific and technical guidance on foods for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013. The guidance presented in ...
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on Scientific and technical guidance for the preparation and presentation of applications pursuant to Article 6 Paragraph 11 of Directive 2000...
The Commission shall submit a report to the European Parliament and to the Council (after having consulted the European Food Safety Authority) on the necessity, if any, of provisions for food intended for sportspeople. This report is required by Article 13 of Regulation (EU) No 609/2013 of the E...
Health promotion and disease prevention through provision and consumption of healthy diets are increasingly recognised as crucial, both socially and economically, in the face of strained healthcare systems, an ageing population, and the high individual and economic costs of diseases. The Foresig...